Cargando…
Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
Hyperinsulinemia is a major risk factor for equine laminitis, a debilitating and painful foot condition. Sweet taste receptor (T1R2/3) inhibitors have been used to reduce the insulin and glucose responses to oral carbohydrates in other species. However, their effect in horses has not been investigat...
Autores principales: | de Laat, Melody Anne, Kheder, Murad Hasan, Pollitt, Christopher Charles, Sillence, Martin Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025858/ https://www.ncbi.nlm.nih.gov/pubmed/29958298 http://dx.doi.org/10.1371/journal.pone.0200070 |
Ejemplares similares
-
Equine glucagon-like peptide-1 receptor physiology
por: Kheder, Murad H., et al.
Publicado: (2018) -
The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies
por: Meier, Alexandra, et al.
Publicado: (2018) -
Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2018) -
An investigation of the equine epidermal growth factor system during hyperinsulinemic laminitis
por: de Laat, Melody A., et al.
Publicado: (2019) -
The cresty neck score is an independent predictor of insulin dysregulation in ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2019)